COPREG: Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus
Sponsor
University Hospital, Toulouse (Other)
Overall Status
Completed
CT.gov ID
NCT04615676
Collaborator
(none)
4,734
1
2.7
1778.9
Study Details
Study Description
Brief Summary
Emergency call centers are very solicited in epidemic situations. It is necessary to detect early Predictive Criteria of Severity in COVID respiratory infection to identify patients at risk of complication or aggravation from an emergency call center in order to adapt their orientation and their medical management.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Actual Enrollment
:
4734 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Evaluation of the Predictive Criteria of Severity Related to Patient Calling Emergency Centre for Low or High Respiratory Infection With or Without Fever and Suspected to be COVID-19.
Actual Study Start Date
:
Apr 27, 2020
Actual Primary Completion Date
:
Jul 17, 2020
Actual Study Completion Date
:
Jul 17, 2020
Outcome Measures
Primary Outcome Measures
- Hospitalization [Month 1]
Hospitalization declared by the patient 1 month after his call to the emergency call center
Eligibility Criteria
Criteria
Ages Eligible for Study:
15 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- patient (more than 15 years old) calling the emergency call center (15 center) for Low or High Respiratory Infection With or Without Fever and Suspected to be COVID
Exclusion Criteria:
-
unknown contact facility
-
call not regulated by a practitioner from the medical emergency help team
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Hospital of Toulouse | Toulouse | France | 31000 |
Sponsors and Collaborators
- University Hospital, Toulouse
Investigators
- Principal Investigator: Charles-Henri HOUZE-CERFON, University Hospital, Toulouse
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT04615676
Other Study ID Numbers:
- RC31/20/0141
First Posted:
Nov 4, 2020
Last Update Posted:
Nov 9, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: